BioMarin Pharmaceutical | 销售和管理费用

Selling And Administration Expenses 更改 日
Acadia Pharmaceuticals USD 107.99M 3.47M 2024-03
Agios Pharmaceuticals USD 31.01M 4.29M 2024-03
Alnylam Pharmaceuticals USD 210.8M 12.67M 2024-03
Amgen USD 1.81B 44M 2024-03
Bayer EUR 3.83B 234M 2024-03
Biogen USD 581.5M 27M 2024-03
BioMarin Pharmaceutical USD 225.91M 49.12M 2024-03
Gilead Sciences USD 1.38B 233M 2024-03
Incyte USD 300.3M 6.44M 2024-03
Insmed USD 93.1M 3.57M 2024-03
Ionis Pharmaceuticals USD 52.64M 18.37M 2024-03
Moderna USD 274M 196M 2024-03
Neurocrine Biosciences USD 243.1M 38.9M 2024-03
PTC Therapeutics USD 73.27M 3.02M 2024-03
Regeneron Pharmaceuticals USD 689M 48.7M 2024-03
Roche Holding CHF 6.51B 26M 2023-06
Sanofi EUR 2.6B 26M 2024-03
Sarepta Therapeutics USD 127M 6.11M 2024-03
Ultragenyx Pharmaceutical USD 78.16M 1.33M 2024-03
United Therapeutics USD 144.4M 15.8M 2024-03
Vertex Pharmaceuticals USD 342.7M 78.9M 2024-03



BioMarin Pharmaceutical 销售和管理费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Jun 2024.